CN111227097A - Blueberry lutein ester candy tablet and preparation method thereof - Google Patents
Blueberry lutein ester candy tablet and preparation method thereof Download PDFInfo
- Publication number
- CN111227097A CN111227097A CN202010125684.3A CN202010125684A CN111227097A CN 111227097 A CN111227097 A CN 111227097A CN 202010125684 A CN202010125684 A CN 202010125684A CN 111227097 A CN111227097 A CN 111227097A
- Authority
- CN
- China
- Prior art keywords
- parts
- lutein ester
- blueberry
- powder
- candy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 title claims abstract description 57
- 235000003095 Vaccinium corymbosum Nutrition 0.000 title claims abstract description 55
- 235000017537 Vaccinium myrtillus Nutrition 0.000 title claims abstract description 55
- 235000021014 blueberries Nutrition 0.000 title claims abstract description 55
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 244000077233 Vaccinium uliginosum Species 0.000 title description 2
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 53
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 40
- 239000000843 powder Substances 0.000 claims abstract description 38
- 244000000626 Daucus carota Species 0.000 claims abstract description 22
- 235000002767 Daucus carota Nutrition 0.000 claims abstract description 22
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 22
- 239000008103 glucose Substances 0.000 claims abstract description 22
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 21
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 21
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 21
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229920002472 Starch Polymers 0.000 claims abstract description 20
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 20
- 239000008107 starch Substances 0.000 claims abstract description 20
- 235000019698 starch Nutrition 0.000 claims abstract description 20
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 20
- 239000011718 vitamin C Substances 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims description 28
- 238000002156 mixing Methods 0.000 claims description 21
- 238000001035 drying Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000008213 purified water Substances 0.000 claims description 7
- 238000007873 sieving Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 2
- 208000003464 asthenopia Diseases 0.000 abstract description 18
- 230000004438 eyesight Effects 0.000 abstract description 9
- 239000003053 toxin Substances 0.000 abstract description 3
- 231100000765 toxin Toxicity 0.000 abstract description 3
- 235000013376 functional food Nutrition 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 210000001508 eye Anatomy 0.000 description 19
- 230000000694 effects Effects 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 12
- 230000006870 function Effects 0.000 description 5
- 230000032683 aging Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 206010013774 Dry eye Diseases 0.000 description 3
- 206010034960 Photophobia Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 2
- 206010015958 Eye pain Diseases 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 206010023644 Lacrimation increased Diseases 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004317 lacrimation Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 206010006895 Cachexia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010015967 Eye swelling Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 201000002287 Keratoconus Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 206010057430 Retinal injury Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000004373 eye development Effects 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- -1 fatty acid ester Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 230000008897 memory decline Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000004310 photopic vision Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G3/368—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Food Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a blueberry lutein ester candy tablet and a preparation method thereof, belonging to the technical field of functional foods and being prepared from the following raw materials in parts by weight: 3-10 parts of blueberry powder, 3-8 parts of lutein ester, 3-8 parts of carrot powder, 0.5-1.5 parts of vitamin C, 0.5-1.5 parts of edible glucose, 0.5-1.5 parts of maltodextrin and 0.5-1.5 parts of starch. The blueberry lutein ester tablet candy is prepared by matching blueberry powder, lutein ester, carrot powder and vitamin C with edible glucose, maltodextrin, starch and other components, is suitable for various people, is convenient for people to eat and carry, has no toxin and no side effect, is rich in raw materials, and effectively plays roles of relieving eye fatigue and improving eyesight.
Description
Technical Field
The invention relates to the technical field of functional foods, and particularly relates to a blueberry lutein ester candy tablet and a preparation method thereof.
Background
The eyes are the windows of soul, are one of the most important organs that people contact with the outside, and have normal vision and good vision state, which is the basic guarantee that people can normally live and work.
With scientific development and social progress and wide popularization and application of video terminals such as computers, televisions, mobile phones and the like, people are more and more engaged in close-range fine eye use work, and the situation of excessive eye use is more and more serious, so that the eyes have a series of uncomfortable symptoms such as acerbity and distending pain, dry and wet lacrimation and the like, and the symptoms seriously affect the physical and mental health and the life quality of people. The incidence of asthenopia also tends to rise gradually due to poor learning environment, long daily learning time, poor eye habit, short myopia genetic history, and short outdoor activities and physical exercise time. Studies have shown that inappropriate light causes optic nerve cells in the retina to suffer permanent irreversible oxidative damage, that the eyeball of a human who is engaged in fine work for a long time is often in a tight state, that the metabolism of eye muscles is significantly enhanced, leading to an increase in metabolic wastes and an excessive accumulation of oxygen radicals, and that the visual function of the eye is impaired when the eye is not relieved for a long time, thereby causing asthenopia.
Asthenopia, also known as asthenopia, is mainly manifested by visual impairment, eye drowsiness, photophobia, heavy eyelids, difficulty in opening eyes, soreness or pain around the eyeball and orbit, lacrimation, foreign body sensation, dry eyes, retinal damage, and glaucomatous eyes. Patients with severe asthenopia also have varying degrees of systemic symptoms, also commonly referred to as asthenopia syndrome. It is also easy to cause symptoms such as inattention, memory decline, nerve aging, anorexia, etc.; in addition, asthenopia may also lead to premature aging and a decrease in body immunity.
Various medicines or health-care products for relieving eyestrain exist in the market at present, but most medicines contain toxins or have side effects, and candies are snacks which are loved by people, but the candies in the market only mainly have sour and sweet taste and do not help the health of human bodies.
Disclosure of Invention
The blueberry lutein ester candy tablet and the preparation method thereof provided by the invention have the effects of relieving eyestrain and improving eyesight, and are convenient for people to eat and carry.
In order to solve the technical problem, the technical scheme of the invention is realized as follows:
a blueberry lutein ester candy tablet is prepared from the following raw materials in parts by weight: 3-10 parts of blueberry powder, 3-8 parts of lutein ester, 3-8 parts of carrot powder, 0.5-1.5 parts of vitamin C, 0.5-1.5 parts of edible glucose, 0.5-1.5 parts of maltodextrin and 0.5-1.5 parts of starch.
A blueberry lutein ester candy tablet is prepared from the following raw materials in parts by weight: 6 parts of blueberry powder, 6 parts of lutein ester, 6 parts of carrot powder, 1 parts of vitamin C, 1 part of edible glucose, 1 part of maltodextrin and 1 part of starch.
A preparation method of a blueberry lutein ester candy tablet comprises the following steps:
(1) mixing edible glucose, maltodextrin and starch uniformly to obtain a mixture 1;
(2) uniformly mixing blueberry powder, lutein ester, carrot powder and vitamin C to obtain a mixture 2;
(3) and uniformly mixing the mixture 1 and the mixture 2, adding a proper amount of purified water, granulating, drying, finishing granules, sieving and tabletting to obtain the blueberry lutein ester tabletting candy.
Wherein, preferably, the granulating in the step (3) is carried out by using a swing type granulator.
Wherein, preferably, the drying is carried out at the temperature of 80-90 ℃ until the water content is below 2%.
Wherein, preferably, the drying time is 45-60 minutes.
The blueberry has the function of protecting eyes, and is a fruit rich in nutritive value. The blueberry is rich in a large amount of anthocyanin, a plurality of vitamins and various minerals beneficial to the body and other elements. It has effects of improving vision, resisting oxidation, resisting aging, and caring skin. It also has obvious effects of delaying cranial nerve aging, improving memory, strengthening blood vessel, preventing heart disease, preventing cancer, etc.
Lutein ester is an important fatty acid ester and has the similar action as carotene. The lutein ester has effects of resisting oxidation, filtering blue light, and nourishing eye development. Can prevent the damage of ultraviolet rays or blue light of a mobile phone to eyes and protect the retina of the eyes. The lutein ester has effects of protecting vision, relieving asthenopia, and treating blurred vision, eye dryness, eye pain, photophobia, and corneal rubefaction. Has effects of preventing macular degeneration. The lutein ester is eaten more at ordinary times, and has better conditioning and treating effects on eyes.
The carrot contains a large amount of carotene, can play a role in tonifying liver and improving eyesight, and is greatly helpful for the liver and eyes; the carrot contains various nutrients and antioxidant components, and has the function of improving the immunity of the organism; the carrot can make the intestinal tract fully peristalsis, and has great effects on relaxing bowels and preventing cancer.
Vitamin C is a vitamin necessary for normal metabolism of human body, and has the effects of maintaining human health, delaying aging, protecting eyes, promoting calcium absorption, etc.
The main effect of glucose consumption is to treat hypoglycemia, thereby controlling the blood glucose concentration within the normal range. And glucose is also beneficial to the metabolism of the organism, is indispensable nutrition for the organism, and is beneficial to promoting blood circulation and stable secretion in the organism.
The maltodextrin is a component extracted from malt, contains abundant lactose, and can be used for increasing the viscosity of food at ordinary times. And the vitamin d and the vitamin e in the maltodextrin are relatively rich, so that the absorption of bones to calcium ions can be increased, and the probability of osteoporosis occurrence can be reduced.
The starch has the effects of supplementing energy, preventing intestinal cancer, preventing cardiovascular and cerebrovascular diseases and the like, and can be eaten by general people. Is suitable for patients with emaciation and hypoglycemia.
The invention has the beneficial effects that:
the blueberry lutein ester tablet candy is prepared by matching blueberry powder, lutein ester, carrot powder and vitamin C with edible glucose, maltodextrin, starch and other components, is suitable for various people, is convenient for people to eat and carry, has no toxin and no side effect, is rich in raw materials, and effectively plays roles of relieving eye fatigue and improving eyesight.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
The embodiment provides a blueberry lutein ester candy tablet which is prepared from the following raw materials in parts by weight: 6 parts of blueberry powder, 6 parts of lutein ester, 6 parts of carrot powder, 1 parts of vitamin C, 1 part of edible glucose, 1 part of maltodextrin and 1 part of starch.
The preparation method of the blueberry lutein ester candy tablet comprises the following steps:
(1) mixing edible glucose, maltodextrin and starch uniformly to obtain a mixture 1;
(2) uniformly mixing blueberry powder, lutein ester, carrot powder and vitamin C to obtain a mixture 2;
(3) uniformly mixing the mixture 1 and the mixture 2, adding a proper amount of purified water, granulating by using a YK-120 type swinging granulator, drying at the temperature of 80-90 ℃ until the water content is 1.5%, drying for 50 minutes, granulating, sieving and tabletting to obtain the blueberry lutein ester tabletting candy, wherein each tablet is 0.5 g.
Example 2
The embodiment provides a blueberry lutein ester candy tablet which is prepared from the following raw materials in parts by weight: 3 parts of blueberry powder, 8 parts of lutein ester, 3 parts of carrot powder, 1.5 parts of vitamin C, 0.5 part of edible glucose, 1.5 parts of maltodextrin and 0.5 part of starch.
The preparation method of the blueberry lutein ester candy tablet comprises the following steps:
(1) mixing edible glucose, maltodextrin and starch uniformly to obtain a mixture 1;
(2) uniformly mixing blueberry powder, lutein ester, carrot powder and vitamin C to obtain a mixture 2;
(3) uniformly mixing the mixture 1 and the mixture 2, adding a proper amount of purified water, granulating by using a swing type granulator, drying at the temperature of 80-90 ℃ until the water content is 2%, drying for 45 minutes, granulating, sieving and tabletting to obtain the blueberry lutein ester tabletting candy, wherein each tablet is 0.5 g.
Example 3
The embodiment provides a blueberry lutein ester candy tablet which is prepared from the following raw materials in parts by weight: 10 parts of blueberry powder, 3 parts of lutein ester, 8 parts of carrot powder, 0.5 part of vitamin C, 1.5 parts of edible glucose, 0.5 part of maltodextrin and 1.5 parts of starch.
The preparation method of the blueberry lutein ester candy tablet comprises the following steps:
(1) mixing edible glucose, maltodextrin and starch uniformly to obtain a mixture 1;
(2) uniformly mixing blueberry powder, lutein ester, carrot powder and vitamin C to obtain a mixture 2;
(3) uniformly mixing the mixture 1 and the mixture 2, adding a proper amount of purified water, granulating by using a YK-120 type swinging granulator, drying at the temperature of 80-90 ℃ until the water content is 1.2%, drying for 60 minutes, granulating, sieving and tabletting to obtain the blueberry lutein ester tabletting candy, wherein each tablet is 0.5 g.
Example 4
The embodiment provides a blueberry lutein ester candy tablet which is prepared from the following raw materials in parts by weight: 5 parts of blueberry powder, 7 parts of lutein ester, 4 parts of carrot powder, 1.2 parts of vitamin C, 0.8 part of edible glucose, 1.2 parts of maltodextrin and 0.8 part of starch.
The preparation method of the blueberry lutein ester candy tablet comprises the following steps:
(1) mixing edible glucose, maltodextrin and starch uniformly to obtain a mixture 1;
(2) uniformly mixing blueberry powder, lutein ester, carrot powder and vitamin C to obtain a mixture 2;
(3) uniformly mixing the mixture 1 and the mixture 2, adding a proper amount of purified water, granulating by using a YK-120 type swinging granulator, drying at the temperature of 80-90 ℃ until the water content is 1.7%, wherein the drying time is 55 minutes, and carrying out granulation, sieving and tabletting to obtain the blueberry lutein ester tabletting candy, wherein each tablet is 0.5 g.
Example 5
The embodiment provides a blueberry lutein ester candy tablet which is prepared from the following raw materials in parts by weight: 8 parts of blueberry powder, 4 parts of lutein ester, 6 parts of carrot powder, 0.6 part of vitamin C, 1.2 parts of edible glucose, 0.6 part of maltodextrin and 1.2 parts of starch.
The preparation method of the blueberry lutein ester candy tablet comprises the following steps:
(1) mixing edible glucose, maltodextrin and starch uniformly to obtain a mixture 1;
(2) uniformly mixing blueberry powder, lutein ester, carrot powder and vitamin C to obtain a mixture 2;
(3) uniformly mixing the mixture 1 and the mixture 2, adding a proper amount of purified water, granulating by using a YK-120 type swinging granulator, drying at the temperature of 80-90 ℃ until the water content is 1.9%, drying for 55 minutes, granulating, sieving and tabletting to obtain the blueberry lutein ester tabletting candy, wherein each tablet is 0.5 g.
The application of the tabletting candy for relieving the asthenopia in the aspect of relieving the asthenopia comprises the following steps:
human body test
The health care function of improving asthenopia of the invention is functionally evaluated by investigating the influence on asthenopia of a subject before and after taking the test sample of the invention.
1. Subject selection
Adults with long-term eye use and easily fatigued vision are selected as a test population. The cooperation persons are voluntarily participated and guaranteed to be brought into the test when the conditions are met; for subjects who do not meet the standard of inclusion age, patients who are allergic to health food, patients with infectious eye diseases, patients with internal and external eye diseases such as corneal nebula and keratoconus, patients with eye fundus diseases or diseases combined with cardiovascular, cerebrovascular, liver, kidney, hematopoietic systems and the like, patients who take substances related to the tested functions in a short time, patients who judge the result, patients who take other medicaments related to vision treatment for a long time or patients who fail to stop using other treatment methods and the like, the data statistics is not included. Among them, 100 cases were used in the control group and 100 cases were used in the experimental group.
2. Sample feeding method
Experimental groups: the blueberry lutein ester candy tablet made from example 1 was administered 2 tablets at a time, 3 times daily.
Control group: adopts Zhenshiming eye drops to treat the disease.
3. Efficacy determination criteria
Ophthalmic symptoms: symptom improvement: the symptoms of the eye pain, the eye swelling, the photophobia, the blurred vision and the dry eyes are improved by 1 point or more than 1 point, and the symptoms are improved when any of 5 symptoms is improved and other symptoms are not worsened.
The method has the following advantages: the difference between the front and the back of the photopic vision persistence degree is more than or equal to 0.1, and the difference is significant through statistical comparison.
And (4) invalidation: the effective standard is not reached.
4. Results
| Group of | Number of examples | Improvements in or relating to | Is effective | Invalidation | Effective rate (%) |
| Experimental group | 100 | 34 | 54 | 12 | 88 |
| Control group | 100 | 31 | 52 | 17 | 83 |
From the above results, it was found that the symptoms of asthenopia were improved well in both the test group and the control group. Compared with a control group, the function of improving the asthenopia symptoms of the test group is better and is obviously better than that of the control group (P is less than 0.05).
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (6)
1. The blueberry lutein ester candy tablet is characterized by being prepared from the following raw materials in parts by weight: 3-10 parts of blueberry powder, 3-8 parts of lutein ester, 3-8 parts of carrot powder, 0.5-1.5 parts of vitamin C, 0.5-1.5 parts of edible glucose, 0.5-1.5 parts of maltodextrin and 0.5-1.5 parts of starch.
2. The blueberry lutein ester candy tablet as claimed in claim 1 is characterized by being prepared from the following raw materials in parts by weight: 6 parts of blueberry powder, 6 parts of lutein ester, 6 parts of carrot powder, 1 parts of vitamin C, 1 part of edible glucose, 1 part of maltodextrin and 1 part of starch.
3. A method for preparing a blueberry lutein ester candy tablet as described in claim 1 or 2, which is characterized by comprising the following steps:
(1) mixing edible glucose, maltodextrin and starch uniformly to obtain a mixture 1;
(2) uniformly mixing blueberry powder, lutein ester, carrot powder and vitamin C to obtain a mixture 2;
(3) and uniformly mixing the mixture 1 and the mixture 2, adding a proper amount of purified water, granulating, drying, finishing granules, sieving and tabletting to obtain the blueberry lutein ester tabletting candy.
4. The preparation method of the blueberry lutein ester candy tablet according to claim 3, characterized by comprising the following steps: and (4) granulating in the step (3) by adopting a swinging type granulator.
5. The preparation method of the blueberry lutein ester candy tablet according to claim 3, characterized by comprising the following steps: the drying is carried out at the temperature of 80-90 ℃ until the water content is below 2%.
6. The preparation method of the blueberry lutein ester candy tablet according to claim 5, characterized in that: the drying time is 45-60 minutes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010125684.3A CN111227097A (en) | 2020-02-27 | 2020-02-27 | Blueberry lutein ester candy tablet and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010125684.3A CN111227097A (en) | 2020-02-27 | 2020-02-27 | Blueberry lutein ester candy tablet and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111227097A true CN111227097A (en) | 2020-06-05 |
Family
ID=70875050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010125684.3A Pending CN111227097A (en) | 2020-02-27 | 2020-02-27 | Blueberry lutein ester candy tablet and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111227097A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112715873A (en) * | 2020-12-10 | 2021-04-30 | 浙江蓝美生物技术有限公司 | Blueberry powder compound solid preparation capable of protecting eyes and improving memory and preparation method and application thereof |
| CN112715729A (en) * | 2020-12-30 | 2021-04-30 | 广东粤微食用菌技术有限公司 | Blueberry lutein ester tablet candy for relieving visual fatigue and preparation method thereof |
| CN115316664A (en) * | 2022-04-25 | 2022-11-11 | 山西振东五和医养堂股份有限公司 | Blueberry lutein ester with eyesight protection effect and preparation method thereof |
| CN115444134A (en) * | 2022-10-26 | 2022-12-09 | 华北制药河北华维健康产业有限公司 | Blueberry lutein ester chewable tablet and preparation method thereof |
| CN116326702A (en) * | 2023-02-23 | 2023-06-27 | 重庆瑞航生物科技有限公司 | Blueberry beverage with eye protection function and preparation method thereof |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005065525A (en) * | 2003-08-20 | 2005-03-17 | Koyo Shokai:Kk | Lutein- and blueberry-containing drink |
| CN104397311A (en) * | 2014-11-28 | 2015-03-11 | 哈尔滨墨医生物技术有限公司 | Blueberry composite tablet candy capable of relieving visual fatigue and preparation method thereof |
| CN104839588A (en) * | 2015-06-03 | 2015-08-19 | 余秋野 | Blueberry and tegetes erecta xangold tabletting candy for improving asthenopia and poor eyesight |
| CN106490284A (en) * | 2016-11-03 | 2017-03-15 | 吉林师范大学博达学院 | A kind of candy for alleviating pressure and preparation method thereof |
| CN106690287A (en) * | 2015-11-18 | 2017-05-24 | 珠海宝德润生健康科技有限公司 | Composition with function of alleviating visual fatigue and preparation method of composition |
| CN107397029A (en) * | 2017-07-21 | 2017-11-28 | 丁伟 | A kind of blueberry lutein ester pressed candy |
| CN109619566A (en) * | 2019-01-22 | 2019-04-16 | 广州硕维食品技术有限公司 | A kind of nutraceutical for alleviating asthenopia |
| CN109845868A (en) * | 2018-12-14 | 2019-06-07 | 西安极客食品有限公司 | A kind of lutein ester pressed candy and preparation method thereof improving visual fatigue |
| CN110169484A (en) * | 2019-04-23 | 2019-08-27 | 广东润源中天生物科技有限公司 | A kind of blueberry lutein ester pressed candy and preparation method thereof |
-
2020
- 2020-02-27 CN CN202010125684.3A patent/CN111227097A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005065525A (en) * | 2003-08-20 | 2005-03-17 | Koyo Shokai:Kk | Lutein- and blueberry-containing drink |
| CN104397311A (en) * | 2014-11-28 | 2015-03-11 | 哈尔滨墨医生物技术有限公司 | Blueberry composite tablet candy capable of relieving visual fatigue and preparation method thereof |
| CN104839588A (en) * | 2015-06-03 | 2015-08-19 | 余秋野 | Blueberry and tegetes erecta xangold tabletting candy for improving asthenopia and poor eyesight |
| CN106690287A (en) * | 2015-11-18 | 2017-05-24 | 珠海宝德润生健康科技有限公司 | Composition with function of alleviating visual fatigue and preparation method of composition |
| CN106490284A (en) * | 2016-11-03 | 2017-03-15 | 吉林师范大学博达学院 | A kind of candy for alleviating pressure and preparation method thereof |
| CN107397029A (en) * | 2017-07-21 | 2017-11-28 | 丁伟 | A kind of blueberry lutein ester pressed candy |
| CN109845868A (en) * | 2018-12-14 | 2019-06-07 | 西安极客食品有限公司 | A kind of lutein ester pressed candy and preparation method thereof improving visual fatigue |
| CN109619566A (en) * | 2019-01-22 | 2019-04-16 | 广州硕维食品技术有限公司 | A kind of nutraceutical for alleviating asthenopia |
| CN110169484A (en) * | 2019-04-23 | 2019-08-27 | 广东润源中天生物科技有限公司 | A kind of blueberry lutein ester pressed candy and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 陕西凯瑞生物医学科技有限公司: "蓝莓叶黄素酯压片糖果", 《陕西凯瑞生物医学科技有限公司企业标准 Q/SKR0002S-2019》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112715873A (en) * | 2020-12-10 | 2021-04-30 | 浙江蓝美生物技术有限公司 | Blueberry powder compound solid preparation capable of protecting eyes and improving memory and preparation method and application thereof |
| CN112715729A (en) * | 2020-12-30 | 2021-04-30 | 广东粤微食用菌技术有限公司 | Blueberry lutein ester tablet candy for relieving visual fatigue and preparation method thereof |
| CN115316664A (en) * | 2022-04-25 | 2022-11-11 | 山西振东五和医养堂股份有限公司 | Blueberry lutein ester with eyesight protection effect and preparation method thereof |
| CN115444134A (en) * | 2022-10-26 | 2022-12-09 | 华北制药河北华维健康产业有限公司 | Blueberry lutein ester chewable tablet and preparation method thereof |
| CN116326702A (en) * | 2023-02-23 | 2023-06-27 | 重庆瑞航生物科技有限公司 | Blueberry beverage with eye protection function and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111227097A (en) | Blueberry lutein ester candy tablet and preparation method thereof | |
| EP2138055B2 (en) | Formula food to be beneficial for visuognosis persistence and use thereof | |
| CN104397311A (en) | Blueberry composite tablet candy capable of relieving visual fatigue and preparation method thereof | |
| CN108157568A (en) | A kind of Combined candy for alleviating visual fatigue and its preparation method and application | |
| CN101856118A (en) | Health-care food for relieving asthenopia and preparation method thereof | |
| CN102225087A (en) | Xanthophyll compound preparation with powerful eye-protecting effect | |
| CN102763847A (en) | Health-care food with function of relieving visual fatigue and preparation method thereof | |
| CN104474018A (en) | Health-care soft capsule for relieving asthenopia | |
| CN109645201A (en) | Composition containing lutein and lutein ester, lutein pressed candy and preparation method and application | |
| CN104544052A (en) | Lycium ruthenicum murr buccal tablet capable of protecting eyesight and improving eyesight | |
| CN108041609B (en) | Food composition with functions of relieving visual fatigue and preventing myopia and preparation method thereof | |
| CN110169484A (en) | A kind of blueberry lutein ester pressed candy and preparation method thereof | |
| CN112715729A (en) | Blueberry lutein ester tablet candy for relieving visual fatigue and preparation method thereof | |
| CN101416741A (en) | Health-care food for relieving visual fatigue | |
| CN105520137B (en) | It is a kind of that there is the health food alleviated visual fatigue and protect visual function | |
| CN108685974A (en) | A kind of cowberry lutein piece and preparation method thereof | |
| CN102150860B (en) | Composition for easing visual fatigue and assisting in improving memory | |
| CN106692187A (en) | Composition for improving visuognosis persistence and protecting eye health | |
| CN104958364A (en) | Production method for cowberry lutein preparation capable of relieving asthenopia | |
| CN102512428B (en) | Applications of zinc gluconate tablets and six vitamins pills in treatment of ametropia | |
| CN110559314A (en) | Composition for protecting eyesight | |
| CN1823838B (en) | Medicine and food dual purpose vitamin micro element mineral calcium nutritive product for preventing myopia and its manufacturing method | |
| CN115444134A (en) | Blueberry lutein ester chewable tablet and preparation method thereof | |
| CN108338364A (en) | Composition for relieving asthenopia containing theanine and astaxanthin | |
| CN100376237C (en) | Vitamin micro element mineral calcium nutritive product for preventing pseudomyopia and roal myopia and its manufacturing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200605 |
|
| RJ01 | Rejection of invention patent application after publication |